Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic|Pancreatic Carcinoma Metastatic
Interventions: DRUG: tusamitamab ravtansine|DRUG: Gemcitabine
Sponsor: Sanofi